FDA Drug Recalls

Recalls / Class II

Class IID-0512-2017

Product

Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in Germany for: Actient Pharmaceuticals, LLC, Lake Forest, Illinois 60045; NDC 52244-010-02.

Brand name
Edex
Generic name
Alprostadil
Active ingredient
Alprostadil
Route
Intracavernous
NDCs
52244-010, 52244-020, 52244-040
FDA application
NDA020649
Affected lot / code info
Lot #: 207386, Exp. May 2019

Why it was recalled

Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks

Recalling firm

Firm
Endo Pharmaceuticals, Inc.
Manufacturer
Endo USA, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1400 Atwater Drive, N/A, Malvern, Pennsylvania 19355

Distribution

Quantity
5,086 cartridges
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2017-02-22
FDA classified
2017-03-03
Posted by FDA
2017-03-15
Terminated
2018-06-12
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0512-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Edex · FDA Drug Recalls